Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
Block Deal
|
Mid-range Performer
4898.5000
30.00
(
0.62
%)
NSE
Jun 05, 2025
10:30 AM
Volume:
24,618
High vol. this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
08 Aug 2020
Block Deal
4898.50
0.62%
Alkem Labs (BUY): Gross margin beat sustainable; stronger FCF to support rerating
Buy:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3600
Target
BOB Capital Markets Ltd.
Alkem Labs posted a solid Q1 EBITDA beat led partly by one-offs.
Alkem Laboratories L.. has an
average target
of 5278.50 from 2 brokers.
More from Alkem Laboratories Ltd.
Recommended
Market opens higher, Angel One's average daily turnover drops 18.2% YoY in May
Trendlyne Marketwatch |
05 Jun 2025, 10:26AM
Chart of the Week: Stocks and sectors with the highest dividend yields
The Baseline |
04 Jun 2025, 02:06PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021